1 the applicant is the owner of the therapeutic drug coversyl (active ingredient - perindopril) which has three registered indications for treatment: hypertension, chronic heart fatigue and coronary artery disease.
the respondent, on the other hand, proffered firm assurances which would meet the applicant's concerns.
the parties are fierce trade rivals, and understandably concerned to protect their commercial interests.